0001279569-18-001107.txt : 20180517 0001279569-18-001107.hdr.sgml : 20180517 20180517134506 ACCESSION NUMBER: 0001279569-18-001107 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20180517 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Correvio Pharma Corp. CENTRAL INDEX KEY: 0001036141 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29338 FILM NUMBER: 18842506 BUSINESS ADDRESS: STREET 1: 6TH FLOOR STREET 2: 1441 CREEKSIDE DRIVE CITY: VANCOUVER STATE: A1 ZIP: V6J 4S7 BUSINESS PHONE: 1-604-677-6905 MAIL ADDRESS: STREET 1: 6TH FLOOR STREET 2: 1441 CREEKSIDE DRIVE CITY: VANCOUVER STATE: A1 ZIP: V6J 4S7 FORMER COMPANY: FORMER CONFORMED NAME: Cardiome Pharma Corp DATE OF NAME CHANGE: 20040625 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOME PHARMA CORP DATE OF NAME CHANGE: 20000407 6-K 1 correvio6k.htm FORM 6-K

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13A-16 or 15d-16 of

The Securities Exchange Act of 1934

 

For the month of May 2018

 

COMMISSION FILE Number. 000-29338

 

CORREVIO PHARMA CORP.

 

(Translation of registrant’s name into English)

 

1441 Creekside Drive, 6th floor

Vancouver, British Columbia, V6J 4S7, CANADA

 

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

  

 

 

 
 

 

 

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

Exhibit   Description
     
99.1   News release dated May 17, 2018 - Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV

  

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CORREVIO PHARMA CORP.
  (Registrant)
     
Date: May 17, 2018 By: /s/ Justin Renz
    Name: Justin Renz
    Title: Chief Financial Officer

 

 

 


EX-99.1 2 ex991.htm NEWS RELEASE DATED MAY 17, 2018 - TICKER

Exhibit 99.1

 

 

 

Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV

Nasdaq: CORV TSX: CORV

VANCOUVER, May 17, 2018 /CNW/ - Correvio Pharma Corp. (Nasdaq:CORV / TSX:CORV), formerly Cardiome Pharma Corp., a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Nasdaq and the Toronto Stock Exchange (TSX) have approved changes to the Company's stock ticker symbols.  Effective today, the Company's common shares will commence trading under the trading symbol "CORV" on both the Nasdaq and TSX.  Upon the effective date, the prior trading symbols (Nasdaq:CRME and TSX:COM) will no longer be active.

William Hunter, MD, CEO and President of Correvio, stated, "Commencement of trading under the new CORV ticker symbol marks the final step in our strategic transaction with Cipher Pharmaceuticals and our transition to a European and rest of world focused commercial organization.  This is an exciting time for the Company and we believe we are well positioned for meaningful, long-term growth."

About Correvio Pharma Corp.

Correvio Pharma Corp. is a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients. With a commercial presence and distribution network covering over 60 countries worldwide, Correvio develops, acquires and commercializes brands for the in-hospital, acute care market segment. The Company's portfolio of approved and marketed brands includes: Xydalba(dalbavancin hydrochloride), for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera®/Mabelio® (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat® (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, and Esmocard® and Esmocard Lyo® (esmolol hydrochloride), a short-acting beta-blocker used to control rapid heart rate in a number of cardiovascular indications. Correvio's pipeline of product candidates includes Trevyent®, a drug device combination that is designed to deliver Remodulin® (treprostinil) the world's leading treatment for pulmonary arterial hypertension.

Correvio is traded on the Nasdaq Capital Market (CORV) and the Toronto Stock Exchange (CORV). For more information, please visit our web site www.correvio.com.

Forward-Looking Statement Disclaimer

Certain statements in this news release contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation ("forward-looking statements") that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. A discussion of the risks and uncertainties facing Correvio are discussed in the most recent annual and quarterly reports of our former parent company Cardiome Pharma Corp., and detailed from time to time in our other filings with the Securities and Exchange Commission ("SEC") available at www.sec.gov and the Canadian securities regulatory authorities at www.sedar.com. All of the risks and certainties disclosed in these filings are hereby incorporated by reference in their entirety. While Correvio makes these forward-looking statements in good faith, given these risks, uncertainties and factors, you are cautioned not to place undue reliance on any forward-looking statements made in this press release. All forward-looking statements made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements to reflect subsequent events or circumstances, except as required by law.

Correvio® and the Correvio Logo are the proprietary trademarks of Correvio Pharma Corp.
Aggrastat® and Brinavess® are trademarks owned by Correvio and its affiliates worldwide.
Xydalba™ is a trademark of Allergan Pharmaceuticals International Limited, and used under license.
Zevtera® and Mabelio® are trademarks owned by Basilea Pharmaceutica International Ltd., and used under license.
Esmocard® and Esmocard Lyo® are trademarks owned by Orpha-Devel Handels und Vertriebs GmbH, and used under license.
Trevyent® is a trademark of SteadyMed and used under license.
All other trademarks are the property of their respective owners.

CisionView original content:http://www.prnewswire.com/news-releases/correvio-pharma-corp-formerly-cardiome-pharma-corp-announces-stock-ticker-symbol-change-to-corv-300650415.html

SOURCE Correvio Pharma Corp

View original content: http://www.newswire.ca/en/releases/archive/May2018/17/c1205.html

%CIK: 0001036141

For further information: Justin Renz, CFO, Correvio Pharma Corp., 604.677.6905 ext. 128, 800.330.9928, jrenz@correvio.com; Argot Partners, Michelle Carroll, 212.600.1902, michelle@argotpartners.com

CO: Correvio Pharma Corp

CNW 11:34e 17-MAY-18

EX-99.1 3 ex991.pdf PRINTER FRIENDLY VERSION begin 644 ex991.pdf M)5!$1BTQ+C4-)>+CS],-"C$T(# @;V)J#3P\+TQI;F5A(B00XH)B!X2 # M'P.#Z:1O)P]SOYHR/SK1""3(PL"P31Q(,P)Q)Q"S,S %LP(# @-C$R(#%LP(# @-C$R(#[Y?NZHE-N9TENVN7+Z]:XE6,;UPP7(FN*;S M(MON88_^.TRG]?WR3,$1G4EF( _&X#2867GK/"OSXN=?:5ZZ/;EQ_Y&/=9E5 M?WO;358ZZBU@\..WR77J34G;N'9]1V_JILP*/_0Y)!,Q1A=M5N3K\VI;.,)H MTKKR$['=QM 5DVWR75LW]$NWA\C$?H/X-=%E).Z[:EUO\FI+/^?5>;7/#^_S MO-FWL[NL@1,^61^)B ?]/NL\N(EH\N-KBZFDS0_GV&"WW,:^F+KUXP%)T8(HK7QS6/.B5+:8VP^KL6-H,4" MZBWHQ?P\1&CM+7$4^3[,88,G @MF,NPQPFF&/38CN^LS&N[QP@9AYN3,RV!D?J($6*$$3>'XQJ]"35_(QA_F@8\'J'! M8-V7,4">,$"P5S$ A5YRZ7OXTCKVC0WPPQC^!K\C3G!%-*B_,4A.I>7@-A@[ M<_1_G$D1T^'$PQW$@Q?R28A##A[A&+;#K:[A/Q#@8!2S/E]E5Z]47'6LN$*_ M3'%]R?^O[)I'9)=K-L:T)[6VC_@RDJE3DO'7D6P@M,5+O^830(?H\LBBW@WMI) ML(V##'>6$ ,0T/"7 , )\3P"0T*96YD+,Z>+18^\]CB M]LQSN>LS%__,4^ &/$S=F'D!CY,T8HOMV;-YD[*\P88F+\]>E6CYW M739E6]$XT*_'Y.9M?77]@C"UN?C;/I#_6&F,69"%I2X^TC8QEUMC8 M&FM/[;/(Y2$TL3C)N!\-5HZ.;/;VBM*8UOM'ZP?IJ95N_9"R).))2M+#E*>9 M64TG@P"89A]@'HYS??'AS15[__K\^O*7+_]A9&VF!1W+.W[V[^O'=_.*&W2RNYM^SQ9OY]Q?7 M[.:7RQ=7;[5,6!>,9;K6/"\VYKT^?_?M!5MC)*41TD6#V?TC)#$ M"TC(1^>#*/.JNY?UE,U%*59BRB[% _.2*?-=+YW\<_'=&)LASY((*F .20NL M-#^VG'VJ<>.-ON9A@X]?II,V6U5 M3V8Q3QRS44YF+9B9I4/_N!1%-E3S$6]4I7=]"7-4R883)-E)V=K6V.^S-R13/D5VK_01W;5,U.M9"WJKMU,V5MM8*_15E679E#8+L1+3,> MPEOZ6[)%55=E6[&;MLKOV,6O^4:4:PE/PG>?)FPC[N5@!1D16R,"@^2/CMCM MZNH>TLW.!EJUX#E\EG+?H8/]WK!&R\=Q[V3-FH?M)$,HEE71<,8N;F]EWBIH MTA9/G]I/9X5#&O@0.L86!=:BR$V,17M5:)?V@=8>+2<\<')HJ,5J$N&9'-:5 M*UA#VN@UO2'+:![A;K639LNIV2, IPHE3D,6),X6+R-DI!,$#>%,"Q?2-M"_-YM[%!Z>744'P; Y2.H^PD^)T< [;BOJNT:)N50G<-ZW<,56RJL,Z&.<[+65I[-1B M@HKG.:UJ Q,5&-4R18.A@\M=<$1$9I:VR HD+GTPA M_:3/8A.04D$S$QF\ET!8H4!S](@\Q ?PMZL:I3.*3) K+=RF'BPKU[==,=4( MG0%5Z!QO(W/RY.Q%D *.SPK"Z?KV;T!I#[SVQ M[_3&>A+@_^I>Z<1X*A5ZNHV]R!Q"@C/[W('^M4$(\1(87#6& M7&(';&\C+EN=#3;K))8 ;R+O6LER"N1N\Z"AB\.5!NT[Z$#B@IZ)(GR',D0< M@1)^..8W&RTOM)5A!X1+%!XM;Z6:ME;+3J=%*5N _0[BT!W0T>F3Q2Y>@()J M!8;7R; '\TP/ 5\A+$6U0V43^>=.42$@T8^3TH_2['&)Q'+M'^V;1N.4_*%, M3LZ,SVP))16=?@$733RJ]-I1YO2$F-2I[V3+&KFV'BE;CO33>6-KUJZJV]NJ M@.7P]J-\LW1\5$/I.$?M!>G >QM75>9%MY+-<_;SPTH42Z&%)GTCKA]\-,1N M#.P'08BF/O-..N/_'G=S?I;P--3+09!V^1AY@Y&?'*WR'ET=*';SL*JK?%-4 M-6)D^RM;2:5H!Y<,.#,49MLMW^6QKX$>#D@/K3X_MJ2_!#D#'43K=[8T:O\T M=SIBJ&] 5)>W74TQU!6W*JE>GK^XN;EY\VGR=_8/>:]70LY3K@I"W:YCFH!! M6?#(5?\[=E40>>2JA 4>AH)@<)7&O?/L4A [5K3G1$V&W/-1U1ZI.=40NA[W M4UIYK(%Z8..AX6 3TVUGP4\^+.H>&Z,^956IC0W':*B(8N9-O/Z# &- ME>).% +>>(.Q8_!4+7:*:GJ)%0U1('Q5RUQ[K6S (Z+54+]52X2N$+9[8(TJ MNX;5FX=V S\[=/;^Y"%/O"^>^WR]K@4U:4^>VPOI-)AHHR#[DV,'W-<.PE3K MFH5C\@K2 8JMJBM8+A[1PN'\Z:Z@K_;'5AT*"I''J#U.@ M%_;*8DL*&G^YGLGN19-WA:@9LCRF7AKEBMBTG MJ$*K'3B[E,<%VLNROH.I"+80"2$TMQU*,%M Q@,0]E3 44J3&/3@!W0YE7XM MXD',4U\O#WALEX\F#"^UI$]NI=&>&B&52]M@^LZ2< B>,Z1!0[[N+M'*PE"U M+HT35S@IM5G7>2")6? M#+OC6[<@/)T X!H:1W4O/@FI,1G-]7-A;E$NA>[P/CGF"NGK5R9F'6>O^O'J MI)GWAY;*W )N*].Z5!AC*'93MH,;&LGN5:-:/7#NY1(U@'I0&G#ZVU3?#Y") M/#"WJ7$8P,]T=>DE'$E[J+JC@K#?[WENC\\).$;>Z-XSH7KB#K>!CIZI+A9? MU^I'&4?/XB4QC[R,93Z/?'RO\[J69[?V#CK]TE6LAP>@YXFKV&&(.]QT?G3@ MW;UID>O5[&U5W1%L;EJA,=_JB4IN"3LO59,70J'_9R=WC8A+P,,X.KIKG'$[ M9P(G@)4 K>A;C@&,E/P +!3RCV*LC3!(G*BQ0CCGDPJK$E'FR=T,62KD98B MCV9D?3]B0+ZABRK)?N0W_ A$QR@:0/31>5^K>Z+!&YEW-<9]<--;?*P-'5Q+ M@A=4 >/GN>[10&\1 T1/#39(U$O-7G-3@^&D (,N"_D(U#/+4N:>M$0&HP5H M#G84;&,+H'X^\YABL"]!EQP#8#.,,SQ+"(0_L?( 9 0\\WWZ3-(P&#X-EKG/ M$A>Y$+,H!2\SCT<&Q3]8',?#;RG][Q_Z*? ]JO(Q2Z*0?I$8R##MXV7NUKTP M]-B\EO*.[M78RWK*8G0HK^"4>OS#0QC&/*'.?RSO]!>.1T:$J(J4]PGJ?I)D MA^[!WH4,S?[H#7]]L/?:R IA_./N_ M , 1ZF220T*96YD]W]IG[W/WV7N?M2X )$\?+B\%E@(@F2?@!WHXTU>%1]"Q_0 &>( ! MI@ P6>FIOD'NP4 D+S<7>KK("?R+W@P!2/R^9>CI3Z>#_T_2K%2^ #(7\3F M;$XZ2\3Y(D[*%*2*[3,BIL8DBAE&B9DO2E#$6\3B MG%/9R6PQ]XAX>X:0(V+$1\0%&5Q.IHAOBU@S29C,%?%;<6PRAYD. (HDM@LX MK'@1FXB8Q \.=!'Q<@!PI+@O..8+%G"R!.)#N:2D9O.YW(RDS@"@:$_DY7(Y+/I+BG)J4Q>-@"+9_XL&7%MZ:(B6YI:6UH:FAF9?E&H M_[KX-R7N[2*]"OC<,XC6]X?MK_Q2Z@!@S(IJL^L/6\Q^ #JV B!W_P^;YB$ M)$5]:[_QQ7EHXGF)%PA2;8R-,S,SC;@?!?W[KG")^)'.C?LP OB!8! .U@(6B ?)@ \R02[8# I $=@%]H)* M4 /J02-H 2= !S@-+H#+X#JX">Z !V $C(/G8 :\ ?,0!&$A,D2!Y"%52 LR M@,P@!F0/N4$^4" 4#D5#<1 /$D*YT!:H""J%*J%:J!'Z%CH%78"N0@/0/6@4 MFH)^A=[#"$R"J; RK T;PPS8"?:&@^$UT(%U(+W(+&4&FD7U"W4*&H&]0E-1BNA#= V:"_T M*G0<.A-=@"Y'-Z#;T)?0=]#CZ#<8#(:&T<%883PQX9@$S#I,,>8 IA5S'C. M&:P!U@[KAV5B!=@"['[L,>PY["!V'/L61\2IXLQP[K@(' ^7ARO' M->'.X@9Q$[AYO!1>"V^#]\.S\=GX$GP]O@M_ S^.GR=($W0(=H1@0@)A,Z&" MT$*X1'A(>$4D$M6)UL0 (I>XB5A!/$Z\0APEOB/)D/1)+J1(DI"TDW2$=)YT MC_2*3"9KDQW)$60!>2>YD7R1_)C\5H(B823A)<&6V"A1)=$N,2CQ0A(OJ27I M)+E6,D>R7/*DY W):2F\E+:4BQ13:H-4E=0IJ6&I66F*M*FTGW2R=+%TD_15 MZ4D9K(RVC)L,6R9?YK#,19DQ"D+1H+A06)0ME'K*)5X*5])4"E=8I'5;J4YI55E'V4$Y5WJ]\47E:A:;BJ)*@4J9R M5F5*E:)JK\I5+5,]I_J,+DMWHB?1*^@]]!DU)35/-:%:K5J_VKRZCGJ(>IYZ MJ_HC#8(&0R-6HTRC6V-&4U735S-7LUGSOA9>BZ$5K[5/JU=K3EM'.TQ[FW:' M]J2.G(Z73HY.L\Y#7;*N@VZ:;IWN;3V,'D,O4>^ WDU]6-]"/UZ_2O^& 6Q@ M:< U.& PL!2]U'HI;VG=TF%#DJ&3889AL^&H$ MXT\F%B9))O4F#TQE3%>8YIEVF?YJIF_&,JLRNVU.-G:?YRF<$RSK*# MR^Y:4"Q\+;99=%M\M+2RY%NV6$Y9:5I%6U5;#3.H#']&,>.*-=K:V7JC]6GK M=S:6-@*;$S:_V!K:)MHVV4XNUUG.65Z_?,Q.W8YI5VLW8D^WC[8_9#_BH.; M=*AS>.*HXY;PKXNKA6NC:[R;C M%N)6Z?;87=T]SKW9?<;#PF.=QWE/M*>WYV[/82]E+Y97H]?,"JL5ZU?T>).\ M@[PKO9_XZ/OP?;I\8=\5OGM\'Z[46LE;V>$'_+S\]O@]\M?Q3_/_/@ 3X!]0 M%? TT#0P-[ WB!(4%=04]";8.;@D^$&(;H@PI#M4,C0RM#%T+LPUK#1L9)7Q MJO6KKH%)64K)2!5(/4@M21-)NTO6DS?&]^0SJ4OB:]4T 5_4SU"76%6X6C&?89 M51EO,T,S3V9)9_&R^K+ULW=D3^2XYWR]#K6.M:X[5RUW<^[H>J?UM1N@#3$; MNC=J;,S?.+[)8]/1S83-B9M_R#/)*\U[O25L2U>^=N[]]AOF/_CD^%[,)K129%Y44?BEG%U[XR_:KBJX6=L3O[2RQ+ M#N["[.+M&MKML/MHJ71I3NG8'M\][67TLL*RUWNC]EXM7U9>LX^P3[AOI,*G MHG._YOY=^S]4QE?>J7*N:JU6JMY1/7> ?6#PH./!EAKEFJ*:]X>XA^[6>M2V MUVG7E1_&',XX_+0^M+[W:\;7C0T*#44-'X_PCHP<#3S:TVC5V-BDU%32##<+ MFZ>.11Z[^8WK-YTMABVUK;36HN/@N/#XLV^COQTZX7VB^R3C9,MW6M]5MU': M"MNA]NSVF8[XCI'.\,Z!4RM.=7?9=K5];_3]D=-JIZO.R)XI.4LXFW]VX5S. MN=GSJ>>G+\1=&.N.ZGYP<=7%VST!/?V7O"]=N>Q^^6*O4^^Y*W973E^UN7KJ M&N-:QW7+Z^U]%GUM/UC\T-9OV=]^P^I&YTWKFUT#RP?.#CH,7KCE>NOR;:_; MU^^LO#,P%#)T=SAR>.0N^^[DO:1[+^]GW)]_L.DA^F'A(ZE'Y8^5'M?]J/=C MZXCER)E1U]&^)T%/'HRQQI[_E/[3A_'\I^2GY1.J$XV39I.GI]RG;CY;_6S\ M>>KS^>F"GZ5_KGZA^^*[7QQ_Z9M9-3/^DO]RX=?B5_*OCKQ>]KI[UG_V\9OD M-_-SA6_EWQY]QWC7^S[L_<1\Y@?LAXJ/>A^[/GE_>KB0O+#PFP # />$\_L- M"F5N9'-T7!E(# O3&5N9W1H(# /T" M OW____]_?W\_/SZ^_OY^?KX^/GW]_CV]O?U]O;T]?7S]/3S\_/R\O/Q\?+P M\?'O\/#N[_#M[N_M[>[L[>WK[.SJZ^SIZNOIZ>KHZ.GGZ.CFY^CEYN?DY>;C MY.7CY.7BX^3AXN/@X>+?X.'>W^'>W^#=WM_R MM+:QL[6PLK2OL;2NL+.ML+*MK[&LKK"KK;"JK*^IK*ZIJZVHJJVGJ:RFJ*NE MJ*JEIZFDIJFCI:BBI*>AI*:AHZ6@HJ6?H:2>H*.>H**=GZ&1DY:1DY60DI6/D92.D).. MD)*-CY&,CI&+C9"+C8^*C(Z)BXZ(BHV(BHR'B8N&B(N%AXJ%AHF$AHB#A8B" MA(>"@X:!@X6 @H5_@81_@(-^@()]?X)\?H%\?8![?7]Z?']Z>WYY>GUX>GQW M>7MW>'MV=WIU=WET=GAT=7AS='=R='9Q7V%=7F!<76!;7%];7%Y:6UU96EQ865M76%I65UE55EA455=35%93 M4U524E1145-04%)/3U%.3E!-34],3$Y+2TU*2DQ)24M(2$I(1TE'1DA&1D=% M149$1$5#0T1"0D-!04) 0$$_/D ^/3\]/#X\.SPZ.3LY.#HX-S@W-32+R_#0IE;F1S=')E86T-96YD;V)J#3(Q(# @;V)J#3P\+T9I;'1E M?WD%0+X#@-PQM&.[Y_HGUQW&= D W[1V=-VFQ_OGI0$(NS%_\[J- MUZZ=-TC_#<#U,(#SUN$U@ZO/_VWYV3 6&"QJ"4"#64@?WK1]5\/. M'YS!?#JB;^/FH4&HW?LN-LW#_,"FP5VCXCG^4^PO8WO/-8.;UMS\H^L7 M17 MX)SBZ.9MVW'=^*M/9/6C6]>,7GSBYT< K/L )"\0;I ^!0*HA*-",;9X-$[) M*["6F@FE5,5SG$14. 8] %?]VCL6=8 '/'^E0M7EBZ12O$A=6'SL=[]FM4(! M<$(*9 @29'"ED $0>V,.,ZK8GP03K)@I!>"P1@C /_Z6(;+CR=A_\H/_]G=5 MNZ/_:2,*OX9OX5N-6$2,T$#,$('WH8^DP^?P(ODIEK\)\^%!^#IR<@&Q0A_6 MKX<-<"=\'WX C\.KA"->"$(;#,$H[(#;H =;]&,]JYW _EGP# F2BT!@$8XR M0=QD#;<;>WP=7L7>NY _K3 ZW".A[%/%'Z([7-)&WF-?$1M7!YW+Y1#!X1Q MYIUP%]R/[1Y4QIZ$3^%_4Q/?(NP1CH(+TB ="G"M"W&>(5SA=K@!]L)-\".X M )\1-=$0+TDCN\B'Y*_43#?26[AZ7L>_@>NBX,.^\T#&6<*XNZ-P#;P"OX)W MX6/X$_P9_D* &(B#>$@FJ26-9 MYC)PC/R7GZ=M<&A?D'N!>XKU\$1_A?R8L MQ?%0,Z (ZB $BV$)=,$*Z(6UN,,17/^]R@Z.PT-P D["*3B+Z_LI/B_";^%# MF(;/X,\X&T=$HB-VXB.5I([TD@$R2-:18;*>;"4[R;WX?)N\0G4TE6;2!70I M[:.KZ0B]CNZG1^D#]#OT''V-ODU_S\WCJK@A[D;N<[X)UT64O28AQXN1IQ7( MJRI<93WROPN6*ZMV ^WP &X&X[@1KY"'R)'F5?$)FJ(A[J:+5M)8&J4S7T>UT-[V)'J'?H"?H8_C\B+Y) M/Z)_Y BGY%VX;O"4V*"F"QFBM\0ORV^*?Y!V.:. ]U+:E^)Q% M:[L%->,'R'.0*RLKRLM*BHOF%08*\O/\N3G969D9Z;XTK\>=FI+L!5!0-1#Q8U M?;E-U#.@-/-\N:6,+==^I:4<;RE?:4F,GFJHSL_SA'R>Z(N-/L\$6;&X!]-W M-OK"GNBTDFY7TGRFDDG C->+/3RAQ.%&3Y0,>$+1IAW#XZ&!1ASOM%;3X&M8 MH\G/@],:+2:UF(HV^49/DZ9:HB1H4VC^:0JJ!%Q5=(&O,11M]36R)42YC-#@ MZFCGXIY0H\OK#>?G14G#D&]5%'SU48-?:0(-RC11L2$J*=-XUK/MP.V>TWF3 MXW=,&&'5@%^WVK=ZL*\GR@V&V1PF?[39UQAMOFXJ,3]O@OSSLIZHNF&"P+*> ML[ @MN]TZ[[&QC";S=S0<^#JYBYN/)2XWL.RX^,'/-'CBWNNKO6R=SB,@^;G MM2WI\>*J?:$[/&P;2WJ4'>"@)#& BV1E;)OQ#:_QA5C)P 9/5.VK]PV/;QA M83G'H[#D6N\9YP+Y;.P=6!#RC"_K\7FC09H[5A*W(UXHJ$O4,>7 E/;XHS:A@ MKS45,#Y4@6 M9.IR1>6P?BX=]?NCN;E,4Z0&%"VNK%;)E^;G[8BV^4:-GF@;L@PZ>[!3>'X M6>[U,BG?/B'#*LQ$]RWNB><]L,IU!N2 /QRE ZQF'Z4V/^+ZC7Q>C2?D.9K&!\8')V+[5OD\1M_XZ;:V\='0P-R6)F)/WNZ*-MT1CAH' MA@GR-5H<9TC;4E_;XA4]GM#XP)Q)6!IZ.!>=35$7%[[2JD)IP58J7KQ\$4!] M>N;5F=^J>Y2U7QU"W"M>"29F88,]_ A$A2[HXB9AL7@2ZL01B% 9[J 7%"1R M'T$]UM^*;2/T)#3/]AG#]I6<'TJ09B%2$/,0=8@:1!-B.:(6VX\AAG",V^; M=<&0- )]@AQ[5QB!5D1$E*%(. GI_$=0+5R E>)'(./X2SB('<3Z,L$&65(7 MY(B3((EX4F.[0D:%>V Q;X.UPK[8C&B#=*$K]H'DC\T(^T"#X[^.\^73C^"O MN.9=2'/YD_ -'F*7<"_70]N)ZQI5]Q_<>87N>VQ-;/UO3_Q6X1K:^JX'K\\Y"AS!<6=M7,:*L M^^\ 2,6U5#$9XAH&,+\,9=V.^R:(=-23*@85Q"XCGSY"A)C P4\X[L?^X] @+(]=N%<]\ R7,\"Y%L7FECV 8=6,!DQ^N[1+JY@"B$=NM M1#2Q\;A+$&!\9VLB]\R\BNFWD#>)B +^'I3M/;A/@#RFQ]AG"?9?H9)!5N;! M=5ZA"$7_KH(BHSF@K.:@R. DU"/LB+6($<2[B%.(%8A[9\ME 0*-S"\PV[R: MHO[$J:S8K,3LXA^H#&UB*VAQW%6*/T$[^2IEOH79]U?I''^O\!E]#[-_1E&W MRN;R3#>8O?U/J>*WT'?,R7].-^8H\TUS\F&VR.QI=JT+4)Z_H2=C;PO!V'GF M<\7[8^>E9V+GN?=BY\4HH@GQF]AY,A6[=<[O\B]"EK !;8SI.\[!Y,'&8WQ7 M?&YU[-TYGRO<#.V*WC.9H5X*>)-D^Q3P?BR5PR#SMQ(/.O$<+%/ZLWOS#(2X M,,K. ,ED"K9S>R"HE/T%#G+_!#J47QNKYUK1)K$-]P/H5-I-0Q)W"%Q\,_KH M#C!S"Z&33T0_MA"J&>5\T,G]._I#.^K9'JS+PCHGVDHU-*#U=U ^[_6=S3MQ4^O\[V>M49U"K%Z&[:, MJK3X/(@Z]6&LOROVOG)&E>#^U.#F>A!3R%>T+7$![G$+\N,AM ,&M ?E[%'- MYIG?9Q3]AW)VW,?ZQ?XH+H>%[&SB'\"Z=2BO27"+9S'],?J93Y&R>?!<$&]& M^EGL$S87OQS[]BCE'\5YD!]L#V8%P!X%2?1IU_ M$?D[Z_\038@6/#,Z<&_W?85^DT&Z0#8(DS")>OYS['N?CX0 M3M(]<6(O8@+R+L,+.^:.SO1S_P" ML0_]6P&B!;$0]?G;9_&Z[3YCM96=C4U2YQFUIFP"R5"R>X(FG1GRN.MLU$!U ML!HC*3/2)4A-LU0_2Q-FJ5I6[U[M?F?TDU'ZSI/D0_B$?/@$A5'C*(6G,6M$ M4*K!PLUN]R;W#O<$\<@&SMWM[G,/N0_RADV&'0969N,,W88^PY#A(+]7W"O1 M7^RRN7'SIPZ0X-G.L[T MG^'V]N:Z*^#L^;/4?9; VAPQ MJ=0"OHT(BKW?Q][O8_OW\=+T/M:_#\*5TN.SI3S.]+Y2BBP@'SZ:BENH\R(+ M)A'G$>_$.81=898Y'D0A0E9*.ZF D8. W7^'[YB2,E+A#%%O?A(SIS!)*Z'. M37$F1!3!H2QY[,C#*&(?XC#B.$+$KCSLG6TWB3B/>(?R9T0U/(U)H@SR"1:P M0=,HFXMB&6X7(2,Z$0.(PX@H8A*A45JQ4@I!] 0=B'X$1X'$'M6YRSUU)A+# M3<6@'_%CQ,N(WR'^@(@A5"0FY^](<)<7OB6_U?G6P%M\YPWD^=V_VDUW1YSN M2'^QNT*^>^#NPW>?OYL_?W?L;AJH?AG73?SO,[Z02UGCF8B]IFD7,.%KAW]A6[-R$.]N6[ MR]U])-!WO(\&Q(!$H:D)#=EL4LDMG@FR\TQ+$9(=<;(Y3C;%R4B<;(B3M7$R M%">KXL05)TEQXI#7(?T]XAW$[Q _0?PKX@7$@0;OUN9ZX;XE-?%R;5QLBM.ML?)MC@9C9/U<3(< M)VOB9"!.['%BC1-+G)CCQ!0G6KD/4JT& MES[@\H;K[<;16F4?5=[$/:XGT5E\![3^<%3GJX\F(%A5?EU^':O"8X=5Z=DG MP-FJQ#U57M>3Y#NS548L-B$K81O9MMU_6NX+#40/AFZ/'O0UQM>S?6QN95C/ M\DK9]FW;MV$.MI,QV,;JE/IM*_$/ZU8J;]:"(,4_!.NV[>\#;6,_B'*AX:@' M(=\^$/7X&J,2IM-F\VF^1N(?&]N^'?Q_Y^S-%R$8Q/>\PGDFKRG#:_+R\#-H+18*Y0! 6P2VY( MTAP4[\\ZF<5K-$\:7E-SD*=R)+FM:;<+1'@I+^FE-%5_GK4_+8_[31I)4X/@ MLP'C%UNFMD0NFRH#CDH(1H+& MZ?BS!3=JJL07[C 2(7:'W>$K(+XT2319'2QG+R["C97C)@U4CQ6X<5IJ!&^1 MG7\Q(=M,>@=^L>?^_AOMZ>6YC3VKKWEQ948UK^:L:GW-6]^Z_HU%6_<'R4$R M;_<; J3>*;?.-$RMJ#"FW_P-HEDYA@WIP8"@8*BEN^\<#W))3+/@@#%RFSSF,AIW^HU=\@Y9L!KNDT^Z'LOE)8-0+S2(C4)(;!++ M3)7-3:9N$]__*8%B>(!T_[%X9[@Z'59E/ MDO?0?[PG9T(OR0BG>3UA?1HE87T8#Z>==^T\MI/+'"MTCR5UC2U:-;8>&?_N MXVJWB52:)LB'"%H"0';PT^'KP8Y(.OK8>QS6KC(E*Y MB+74;>[Y8#UY;3VQKR?KSV*HL\/XQ5:FA"LC*TE;=+@375\S>7?*]6AS\_I% M3$/#QBGCY2V1N,E3$W% M.XN8F4EL4T"H?I4,\IZ&BCB38VLI=Q'GN3;N5 M.!)E33&OIH1(E&@)Q_';=GYVXH;K5O^3FA"14U%1G763VL1G>4X5*$?THLGG=_(O-!&.$I[<\;/+#R5M7[OSD8:;K'5ZNU:MK^)$D=3I M1(.8(NJ2Q'1S_=W+7&DSW\HP7%]2EJ,JY:__XXE]NWJ_-G-'6GKS34L&G#:K M7J+"8F*@*MYATB8)-*G\F*^O9)ZP/9S^6_3/^)^H7$C0KZ(JDU^=SR?T2%^@WJ NK-U?3XH-&'9G4 M$=W9M(,OHY4PRZY"RYY&'9B.,$^%CHI$(&(I*:_EBHMX% .::IK"SP+""$D3 M)3VQS=JV(HSBHEI26A(@K,F*0M^>9UZX[CPIZMDZLW?FNUT+*G(7JC?=7)#D ML='O+K\UK;)0HKQ:YS>G5J5NK=QX=E0K<%+&*_1_[;YAQ3?&BA^XY?O/S%R< MV:A5Z9/XVOU+"G:UTWL6SUMZ[L[N#%W*@K2]J<5%3O^:3Y_M/&A1>1_^'N/& M8N"$4X('!M#:6^2?VWW$N-B33K4YYCIC)U>?7I]1GUF?59\MF-/-&>9,D[.QS7UUIJ:^O2A[)SZEH5"T_*"3FKLM6_J=]+>/F.O M3@T[:5]X27BY:G\Z*2@JX0K3LW-J>&_]VB6= MF]NV;-O:,CJX<($ZP:#A5%9.,D? TB])9K/%HND?7#"ZI6=;7T+" LW:@P;O M7=YCWA][>;>WPTN]WD)-Y]B"/DWA3/^89M:&+TVCF<4/E&E&+D]5&ZM9@CW, MT$QF!SKA64<X-QN>) TV6H,= M#2BO)>BURTJSRK/PS:0;(,S(RNW%05(6/\8DQ43CUHCGF$_*\F7ZLM#U2W,F MR,X!FT-I9Y4R??B79B"BGZ#%$N8'2DMFFQG0S-'ZESG7Y@@$38E23JA:[*)\ M4:ZCJ44LO6%L_XN?WG2;SIKK/%Z=,3\_420N:TF.)[!:6^4RIN6:\D:*K*FM MUD*.%Y+S%U7P%B'GU]E.[7BPQ$_)N4+[B4,^9T9UWF"!E^#XE#3J$PQXR"SY MW:Y(V:;^\_-U@E"M5:'!B[I7#JQY)->67)T[B()1.)H?5O& MX*]6)=AH2O;;3YG41ON\)$(M1"TE25IZ/[UN;7"S*\MJ$"P'EFPJ:$4+6QO[ MC#LO%*/;Y>3[-8E"K=MNKRVM?\W1VA.U3]24UH9H%M7QR M+:FIM7.6LJRLA#0#N"$ 0> [8#/LA;M8^->84/A2FO120G\C5]:?IIYL);66 M&COOK"O<'%!OYOGYQ\%)G!/D<=E9E],3"!B/'ZZ+UKU43&4@$F%O5LS4*!(YH"_PZU&U\"C8 M$@\/;%8#8;X"A:[X>>;-4XD2!NFI+TVIRBHMR582>/>)2LSO0")TZ/+R%JY;M:VRXHF:[^=7Y_LLN:E[#FQH&MQ5E"#P NTKU+O;AFO* M]G>$>RP%PA:)Q0$: M\MZC7?VZE E2).=V6HC%HJ/SPW7A&I5QU3NKJ-YL<_&V3']!2850EM>ZJ Z( MP#5&S$^3=R&%+ <;K"#+97VDKFY18]E4=EY/;N,4'O[O_K ].[M]LXW8)LCT MX[E]G>VD'5.R ?[%$RF,G(IP\R-RA$900)E50D&7LK36 DA?([;6:/2&1.?2LX5\0C6&?VJ^E2'P-GUZPX_G7JD MTH2-[#7#V1HJ"2+5J-TG5WK\W4FZ@@1WN5%HUPJ%!IYPA*K566HC(:';P\5. M2P*7]755 B_P64FWSKP^\]S^D$\2B4%2IZO4)F+0\0:50Y6B3[):W+N(2*Y[ MP*M6$]ZIT6G4Y99P 5J>WNB'4VJ%JAO#27J()D[! ,WOSB\/YX4+:K/:F MY>2758LESH80Y^^V$HW9VMHAZ'Y$_AEO+'Y2(AM*)CS0R?[CXBB^*.!A<1E% MAX*,GP-X_T$Q3K/7Y2E%THXK?K\MFMW9(^N<7J?5.UH=LE97APX4)/I56!?V MLU".*&+F2A49HY"*[;;90,U-6)3F*+=@:=Q0%>%A1%:D1/[Q^PT^'/I0$9T_ MDSEKHE7BA2Q'B?;ZGZ3VU7M;Z6I3GDU+O;[%6[VN^3N3!9739TFIUQ>81=Y\ M8O'2'1GD1KL^(7/1/K,_4+*%2K)L%K-!"/+C%@TC@:?C'S>.&( M;%AOOK.,TM1:O!H3TY,)2781_;<&;7VO8(>'R,_E=PR)AB978FJ3N]GXL+A^ MP\B1KWW]GF_<^\W[CAX=3DQRNEPI#0W!QE!3<[-C]7!?0X.CN6&D822XR77H M4,J1(RF'1HZ,'!D^NBD8'$TY9$U).71T>'A3LP/O#(XJHR;[09O#E>)-"S8T M#PX-CVS:NNW0D:.6S+;^';?RMRT)]V&@\6"O+@QA369O2;@@7$1OZ[TQ?'UX MKX;N5;5U='+MY57!9K[R8@I)2_%F%Q3B*.+J/%=#/Y>K[SLR8G3LN);;A<-R MMA.''C]T[A!WTZV'CO);'H2;'X)=QEUTU]B6">)_[.:;'WS(.$$VRD;;^(,/ M]CV4UV/(=>?2W#$OULI)E97M=_4=ZSO5Q_6-K1Y_N9T8V\?::?O$0X'+D2UQ MMW+Y4F0J'J7$WY%9GS*KAXK7,#EF8Y;*2-S;H'8:IRXQ[9PV(I#&RQ4O,ZNF M3"61*%<+$K]BD,H#^J^6X(L5/O^\"A\]TG@N_JM^GBFR!<\1-RE7[B)XR(@V M13'9G8)B<,.BGMGX!=48KQ;E=J]R95'.+CUAD)3+R:P7=E5#RN=C;&9"97JTNV)AK(DP5VQ?O]V MHX4:Q"&=C7"M\J"V^CN>L.LE=DH.7#JUZ!7&F5X@:JT".6@K6W)WD33"4 M5_YK1Z;K&D[@FAT-UR?85,'O93NK:/LRK9YPHCVO;:=C/"_52A(RKC&*-$5C M['0U!=Z2LGG.Y%R4:RIHKO1:2C=4R;ZJ-&UA?=*B'L(+-O2U1$ 7B3&J1$V< MRJRZ8>GMQJ;'&[P:M5'+H9N5K!K!(AD)+XIX4];8O5+._J?25/L?^XXF#.(#7.&J#HB&G/V=SSJDRK#&V>%H* M6^06OF6"JF5G0DJD2$K00FV0X\O*-97MLB,I)V1L3ZK$$U;.2^HN^V6(N$.> M4&&("PT9C?Y.GO!\YX_+7BZ+E7&!LLZR?9CD@V6D;()\(J=[_++_F)_K]$?] M=, _ZC_L/^Z?] L=_GU8PAG\ 3_U![9NP']/E6B6$ MQVA+FWO0@3?AQ$7SJ[I\_@>V#*]*J6O1UOV%\UJ+BI99 M]!KTX!WZ,H\^,?WN8/?NSFWY''68M:K4F9]5WI5L+4FKR"HU/VN0-$*XH6[) MPO;ES=[&AFPQ>75FUH%YJ9FI]IH\R>*6G#I[9<[\3?;DJNWW/G*M.]=["_T5'G_QSCSV?[-C'_ KA KHAHWPJ;S&> VY,$+T&PUOV46NKWRHLBW< M' KO[AS:R$N=VLJ-G<&!X&AP7Y"/!B>#YX-<,!CB)3L):=/0*_(UI9[\[&QW M86)R6W-KWTH5[W9&;FYA?G97:7Z/5+R,QABE8*$[U;V)41.6=G= MVEVSIQ0V&#?0#4.E=[N[2+"KHZN_ZU@7WW66"K )0^*MT],1X]3T])7O)'@W MBS_Q2#A^%XM?S68](#=R\E%BJM M)4$:]T 2QLP85SF4CR0VY17_7I)"K'\/J^+?%+.8%C#Q*R?N[)4+O9LQBWVA MFSW [40UKW=IQ:;5>.MR&MK^#_M6&MO&<87?7KS%:\BU1)'T4C9#419)B;)D M\U DR[0.ZXK=6(Z$4@HE4A)M2CQEET;2!*F1-D6"JB[: LD/!RT0. 40Y.F6!:]6,&K0*V(XEF6H=X0ADWU0M G:8.B)N-M(UQ&+>'1U MZ(NCQ5/,VTZ+;[2-T9L*X^V337[B^BHGM'AUHXU'SSX?:N:-'1J&+I*LTV"Q MN^L]GNAR;^N4V>BWZBSN0TY/U\$VFWET?]0H,#RZ6':#8-MK9>U"BN@:T&J# M/UM[8^-=UMWLTS&]1T[/2M[VPQ.I[U[%43*YR?%I[BD8@CGX47_WTS'FM3EF M J:BQWM:FPJ>@,_/:E@NY9_V3/NFTJGC#_484UI.XS-;,XRGJ5D';$>$SFQ] MV,"="#<_;!)>1NNSC!8XY)I,':?"$U.FP,/A*4+%'"9(6]&)7C!]O2\YF9Q+ M7D[R23H.'L1Q0(?!.QOH8>$8^-LMQ5U.RMXUM6V:VIP:VRJ'X71_#9UI98JK M)L=9BYV$YG2J]N2T.Q95'6@T))W$.%7IR%!]*5:9],KF&D?//8>Z,7PZJ.S# MRMLU(E?4:D_1R%TQ/P-+!N_-S\\.T/T6C-OC3KB;K2WV5;[\E#H^.-C MB<6AKOD#@WTSB=?%!J/U<))Q9\;WQ@-MWK9OL&^YGV3(5&*M=&S^H%>2VMM\ M6_!*H]UD->H:C(8F1M#A$R')&CE#,%]_TC>H,YVP-!6O9D;7*_>X728OV?@< MJA%P^-W#?WYBF#2T>1^9_LHUNG,[L_4G=I,[#6/H<=V22,3[A4;.F@C8 PXI M+B6D7HW@A(33:8U9XX(^UN/M2G0EO]DK-,>D9 N]J'DJ#3>U3_J/=8OQ.(,RW$\[/>QQ$[N)UG"GR??$]\0.3]) MD>OD-^)[HO!K$WD8O&D2/B&:&AF,LCT!2>#;# XX.-G.J ?GH47@7^4 M_JMT()KV:1O2 \;U"898A9=PW &$&&U_@/W!?H!3@'PVL!YX-_#S _SC M! */6!GTS3:O7^YC^G[ ]%TOR0^:S?X#S:?T$6!B'<#LQ4?AUV =VQ F,0YX M$SC:YGW /8BI%X&#'S*?AW$+[<6"[+FT)*0*^\ MOY!C^O);=-6:3<_BHTJ.ZM,V>1W#N,&/<8,A&8^?$XE#%,EVN#]MZZ)^5AD4 M\6V/2_S@C0#=^,&%30D5:.30%175;0#UY8@<+SK4+<;M=R9*<#'C-6O-^A[; MOI8]G3Y_WTQ+5]/KSL@(<;6W>M:.SJU'-2+GLAF(WM*1&S@6:=F_[_27[IT9 MN79%3+?%S ET.:R,5\,8YAS!)JO-="(BA41C5&?O;XT%QS)^=]CEVO.<1:O3 ML6;W]$BK)^IKV6?W>-HJH[5G#(*%;]+81B]\].NE;Z*P"&AP!,WU%@7E9@U]T9Y,T=8 SU+V//306NQW>QBUWL8A>[V,4N_O^ M,:[R]9D#/7>D&!=" W<\N$_-\6P3]^SP.J, W3V'( :);58*,*B&#_NX4_#? M=/!0PG,C6/%6=2!!'(["I*SE Y"!+)2ANK6%$DK.!)S\:,[6[S[I]_$O_>ZR M2[BSW&%%2: 2_[ MMDJS8.9,*LU!*^=2:1[I 976('U&I;7P6^Y2*K^4K^4OY+)2-E/+2 O%4KV2 M7UJN2>/%U6*M7LI)]]=+Q:5*IK1<;Y?&:EFI,Q;K#.&I.RP=*10D6;HJ57+5 M7.5<+AO>*3B4J616BJO9*U*^*F6D6B63S:UD*F>EXN*GUWY^.;^P+*UDZM)\ M#BM=RE=KN0IJEU^5%G*56@:O9]8J^6HVOU#+%U>KX;'4R.#P^('MQD(#Q4+V M;GF?L:HX9_*PA*@A+D .QYJ$R& Z@]0"VK@$=:C(4LO(E6 <>:N(&O)+6$+" M$4RI(DI4L%0)Y>K0COPQE*'U=>(DC>$YI%+=$$;N$2C@3_I0W54YE<-K#J_G M9&W"G]CB$+9#VUJ1<[+P O+RR(1A JH#4?UKN?]L"\JK'?AMN0Q)^ ?(W M$A#!-1BXR^S?Y6<87?'8Q45[=J@P9TG^%9IU\A)XU?S"!KV^?.GVPN:O-C3Z M![2W,:E72\#[ @P +A3A1PT*96YD@M\5-6Y[[?6?LU[]DSFD?=,,IDD9)),DDEF,B0D M.PD)@0 )CT"&$$@@X2$@"0$$JA(02XVH442M6L7@+59Z3H=@,:C5>&JKK2UB MKVCM"U3T6#5'M.AMK[ M?LL7GW>\"R#=SOT<(,4-$-BVH:>K^UQPSEF U;_"]8(;L,.T M0-,.H+V(UUD;MFS?=?=3)]X&T/&(E9NWKNV"W?TBP$)<3]>YI6M7K]3)C^/] M/\3Y[FN[MO0@-@?IS%Q)?8E]M\RZ07@<">" ?[Q M=ROBQ7@S]D]^\"]_5\V[_Y].XO!X#JZ'7,B!1X'B448"D ^+X3#1PBQ8":>Q M+Q>VP5$HA6=A$$S8=P-\%WCP8G\A!& 5WO\$7N="'1R#"NBAZZ$ *JB-2X4L M;)7!(E@.Q^$I>(V, X$2Z(*M MA%=()?DK-P!!",$\6 ;K8 ,<@C^2-.JB/X<,\.'J8:C$>VJA$WIPU7UP .Z" M!^!).$M$LH/L)$-4H?UT#SW&B9R-WRH,Q*X%-^XV'Y\64N^-0 ?>O07Z\.[# M\# \#C^"MTDIV4YVD8/D/O(!M='WZ&5N%?<)G\7/X._@ /H*_P 3$2 I)(QFD@LPF+60I.41N(\?("'F&C)'GR0?D8_() M3:(%M(BNI.OI-GJ$/DI_1$?IT_03KH;;P_V.]_-%_'>%:J%;&!%^(1X7+TJ- ML:VQIV-74)L<D*(GMXC;Q>O&H^+Z4*P4U'K@9AG$O7_\] !JP\5^B=0-]$#;3 M^7 2-7B0U,)?B(E.<.]""C31,O(_0*1^M/\J82[]&7P&OX)7<':C*$$_F11N M)$%81I:B-#\A'T$;>9]+)+6\7[P>'D*N!V@_$-14/SPK#*)OO$./H85XJ99[ M&4ZA]=^*OGYM[$IL'.TCC%:H1W^=!W=-FI"[V^!:M.@-:/EST5J?1@_*@%:E M/%P>*@V4%!?Y"POR?7DSS RW*STM-24Y*='IL-L2K!;9;#(:]#JM M1A(%GJ,$\NL]#9WN:'9GE,_V-#86L&M/%W9T7=71&75C5\/7YT3=G>HT]]=G M*CASW3=F*O&9RERNA,J"?'>]QQW]]6R/>Y2L6-2&[=MF>R+NZ+C:7J"V M^6SUPH@7&1EXA[L^<<-L=Y1TNNNC#3LW#-9WSL;U3NIU=9ZZ'EU!/IS4Z;&I MQU:TP=-[DC14$;5!&^IGGJ2@,2)7T7F>V?71N9[9C(4HYZWOZHZV+&JKGYV2 MD1$IR(^2NK6>-5'PU$;-/G4*U*F/B8IU44E]C'LCVP[GNVME6Y3KBK!G6'S1.9[9T3E[+B46Y(^2[R]MBVKK1@DL;3L#\V(#)^<. MS)X=P9F#7/W@X,&O3R_(;UK.H/N1F#B]M4WG Z2?3CXUD?VT!\*SV> M>M;3>8T[JO74>C8,7M.):D@>C,+BW1DCR?.4,[&+,*_>/;BTS9,1K4[Q1+IF MIYZTP>#BW:?F*NZY7Q\IR#\I6^(R/&DR3S4,QJL;/5^-J2UU.FLAU]-")(PC MSUQ4?M2]UHV]R#GP&J MV#/^T==[NJ9Z1*_\&; F,X2OC G'I]M1GR^:E\=L0*I#I2%G5>IU64'^SFB3 MIU=V1YM09-#2AC=%9OI1Y!D93'^WCBJP!B^B XO:XM=N6),R HK?%XG23C8R M-CUB;V4C ],C7]W>Z4%#?0)8G62/:K*_^F>6'0GU&V9&B>/_,-P3'T?'J'>? MY 7O8$M;=M?@K2G9G8.'(JB:!G2RP<$&C[MAL'.P:S0VL,;CECV#)YN:!GOK M.Z>W-!I[ZM:4:,.A2%3NW$!0KM% 7"#1A+HV+H5&XBV:PF&K:8FG:=&*MG)5 M;\ 8$]^=P!I-\\[DI*TZTID#&X@5/@9@&S!7<$6L4C,$\X M#R&R"1;15O@>;8V]QFV""AR_$^@0#$_ !787BW: M(8>>!Q\]$5LB? @S^2.@%T^ "<>21056X;QL;'<) 'G<>5C ?QC[4C@!7ESS M8\D>^T@X CI!0:I (_7!.>2YC_IBYY'6\A"[0D_ B[CW6MX.F5PK+,3^.D;I M$>A$61BQ/QWK1U9#YN$^2I'J\'E9V.]!S$4DX\2>&!O(9\GL3]W\/VK0+WS?8\O2?&/^/I?POD[9L@ MYV,35^'+JWC[&E2^KL8F+!A]L ;7:$:Y5N+U=I1U+W0SD,Z M[H_)BMG(8?%\;-\4G\7,)A!WJ4 YXWU^7+M2> )\:$>%O +Y*.\):H<4)B/4 M89@_ ?.0GX4HKPRTB=WL7GX3+$?=3;+UT1;2<,R (!J #YB-3LN*/5<:@-6H MUX5,?QH$ZBF":,2U-B+6\=W@Y*X@'RAWQA,9F+R$^GB7' $3PL*W0@31@?MU M,3M&=.#]-1H?S%6?@[KXBB)4^[L*C(=IJ+8V!29_W.-A1!NBB\F+GB >I&\@ M".*'B#.(N_GS8$4_6L5LEMD-LT]F(\P^T [,O ]6,M[9'IB-,SN;DO//\+[M MB "B4<2V"MP_KE')?(;9+>/SJ[71OIB=3%-FX\R'I^Q_'-MAME]F7U_1UMBG M*OW&O:I_^J".\PCX63]!/ MODE9;%%M]QMT6K[3E,4>YO^,HHS+IZYS5']&6_^_I6K%Z*]\V]D^F#K,;DS&:M^-Q5SA6LQ)C#;9SI#NQ12H5+=[S#FG9WH#QAO M12,8Q%)8S^YG_=P?T=XFH87[+R@AKZ&\6J&5]>'US=P",'!OPC)UW!"?P]T! M+>J\!S&VKH9$O@8.X;MUECK^"<:Q5S!6?0ISZ5O8?A7I%WC-UOP8K\]!$4\Q MWMV-.>JUV/MJ/[L'*>M3XZP>^5T$>:I-,]U-^S;:E?1X[!/I/W'_1LPC):KZ8B[D(;4I,15O"W*2.V9"/ M%6!EX MC?^,GU76LW"RH%BN0(G_JO1-8+[!GMZJQNR^>%UG.07GL0#O]=[S? M@',9#RQN,7X^PKC_(LC3-OU-.FWC(L8B%H]8_"8^C!L /9B;]G'?CKW/XC?: MM)'E*)2W5XS =:BW;@V^[_._AA48_WHQ_BU$=""68\YH1O_[[C?H?0S2>7*- M, 9CZ/OIM\$&8N/,D".&>IC@^,H4!1![.6Z@!LI\!:S$9:\,K MB*UHVT\A0HB]"%8O>;&_=3IWHC[&,-:P'#87L1RQ5-@$OQRE_I&-.:Y1.N-T M;\!U9$L F]DC/8QX1W8%7#5&FD]SP TNFHLT@#2'9JDT:V283#XV72/+UKM&R7LCEQ?@5=I(I!M)JF+?G.Q:U:^X7EGS2N\KP]R%-1=Z M+PQS/Z$IY'>P$]=+)K\;V>ER/T<^AR*$@N#($Z1F).#ZKU%2)#Q')WJX6"(U"@Y1#[K/JN<;3D[OS<\.'> DVN22 8^+0-K^@$\$S"3C[# ^0B?^1%4(YH1JQ%;$7L1 M&C*N)#_TDBL$SY.QY\\]?_'YR\_S\'S1\Y2UZ#/D/?(ZE.$2USRY)N#:V-/M M"HT2ZZGV>QBU/(FT_)'#R:B9BXK],"YS^%B)ZUA[I6MC>XFKO*_])1S1*UJD MH7O:DUWEHS13L?9DNWJZ>]P UO*HO82B,5HM&:72/DOZ1QA(D M6^)D0YRLCY-U<9(<)\XX<<2)-4XL<6*($WVQ!W(PXC[D+<@-B%Z$/T(C8C-B+6(-H1;>JZU\27[XZ3SCA)BI/$.+'% MB3E.='$BQ FG>)!>1%Q _![Q'.)9Q*.(O8TE%JU%.U2C(\= 0AO^GGJN5L]^ M19&&?BH-?5<:ND\:NDD:&I"&UDI#JZ6AY5*6)E/CUJ1K4C7)FD2-0V/36#6R MQJ0Q:'0:C4;4\!JJ 0QM3=&QM="TQAW]?(D'65NT(BIX:DG4V@1-2VL3232! M:Z)-2VJCY;XFU.+B:,C7%-6VM+>=).3V"/9&Z7?43S^X9=9U=*1F1 M6H?<6Z5NH2(C\<:4I_"EXS'0^R)1@Z/C2S8U]J0CP=W#S8U=] M2)YW!(N+DH(!4-5 MI*PTIY#D9.=DEY6&@H$2A]UF(DN)P;!QCLW69=:9=0FYOOF]+<.3#[I$H613 M7JK=;A=YV9[@MWAVM,VZO8WQ.9]TTE+R+-BA42GD!2HE<* QK;0(*[F5<,*R M4I< -JE5\Y\MMDY;KVW =M06M8FRK<5&;?YM'1.7+.$P^*],7+HD7PI;G&$K MXR[@##E#)2XB>C)SLCT2$C\I76Q:^.TU@3F9M"K;DU6DR[,FW>"GY"DB<%3; M++"_TNG3+(RC7;%W2",\!WKP/L$]JM6)&!L5$X",-006_ 3 :+!8P_Z^CG&H M'B\N"I7&-X^/R=Y5X\N;.Y 2$1=Y@#VY2ZE'UO M6HA%\.Q;KWD2@X4QYS! &.;"4NB& ;@3AF$$7H7WX5,P8!QI@2&@6F1K#B*H M /DI,/4]IIA?=!/WX9!ACF&989V!-_@[QCLF.OI6=>"Q366M8QS_%1<1FV0B M^ ^YHV6EUBJ"S#H=4C;JSI,I2J)%=@1*@M8<;L": R6,1%W]%V:"'=<8DT4]7CU1!C5 MZ\U @PNB!09G$32\A%!.:8C)GEFA:I=Q8^10(W:;T^$BN%T[?7TR2$S>F5DZ M5#2E]!V'QBJ9RC2SNE;H;/IDHT2UHFMV/J]#:C%*!HLCH4J_(I/P']Z2_O"P M18.OF.E\R:*5(K&4?7ESF[O&G*67]"8]KTU@'AS"][[CJ.,JF 49Y=S_N*20&EY@^0-X!W!L2!7'=R*#2Z(3C'>@9(;'T>/D"M1% I]_ WR"U"(5A,0[4[):7?:)">Z$YHWNE$.^I/H M%,TD,R>(SL\D'G>Q3"F''7$5)%11+I1C0=.2@@&AA#Y<2#B1I]0^9W8YI55" M2:[LHU24JFPSU++%:3#W&(V!]>7915I*4YM^VKBF,Y>0Q7<==^4[B#5=2'2) MAP\\V1#$^P'*R;&01GS-*_J04%OTUW6C0-7$U-5FP M8D6D;+2,EAV&Q+%$FIBX6LYR9Y5DU6:-90E:R"+567[FCLR.F4I0['YG0+7C M2^-AM3?L+&%"1YF;Y,H77JADDL>WW&FAH@@YYJ].AS.=L+_(F3A)#;EE+.2H MANU$YZU"O\;IJ!=4$=,!ND".ZB!L4@AGQ%LX3C_OK0^$7>(>+4\X9\'2^N*$ MU7DSY[HF!<)?%;!",:(-$A^!D MR2+)XMYE,U:%4\VBS&D$PN_7G<1B<'?L M$K=)2 <%GC\#LV*7E11G8O@>D=!273D5#+2$\AI!3X.R(S&<-DI:E*W)KN1] MF6W\1GZ0Y_B_0F;F=<)5*2%Q2<6;\-^>;Q#'@_+EXJ+?*2OKZ\#?*@FY@OLP$", M6K(QG1%59\R5F(:G=(G'U$PT OHKU ME7LC*7:-T90\3R\M32M**LRRIE.#8$](K2FVG)S4\O+DW-UA?2[=5A#4-T+[NKBJJ4JK$JWE^UM8I6L<3)I(<> M$$!W" 2JQ\/,-Z8\@90D^C&'!YG9!T(!-?+@P3'SQGC.?$,52X)JX662)R>3 M1::<["FQ86AB&2&XY5NOKMXSS]GEU#CUR_)FW5A@=)HLAKP$B^@VS$S=5EPH M:^Q&_0&QT?J OW9F&B627M!;">5XRE]F]8!&,A3:7L2\]KT]11TS$LQN6:[H M\IQM)L$#6[UF;R+A>?9_%RK-)DZ39$@/-2;I4&(K,-MW8IP)PFU*SY$TPH,^ M0'UYA=E[//L*"_5M*7]+H2G[=I8>+*6E@OS7D#ZBIWHC&(G1Z"K.RW.A>?). M/HXKYH>*CQ?1'Q:18-<4)A(7% M>K3&J=3/K'+BDI6E3-+7H69!&S51'YE.GZ&@M:R450&2FB@#)=4$96Z/UPIJ MB''0E^>Y?9VWW/.'>1J#SNYMVU6]:6/C@5DMY0L: Q&W"5]Z#'I'V/.MGU]X MH&X=_W3+PFOO?#0&3^_NUAK-.L+Y*AOWD-+G'OYYV_QK7GJH71$YG5G6ZG07 M'__W/V>SO+DC]BYIXI+! (D05K2Z1SE)?M2AEEPCT)J@5EZRD8 1WY*-W,58SNJ9^379B<5Y\\4:GPS*F;Y M2H+TB6REUE>HS5AW9T2F^0/J?5*$W3!266W+"MFL_)>Z'^%:&B' M>SE9OCQ9A A'[U>($A$Y3^3[\W\^__7YW/Q(,LCD,B9C63:OFKG9:#;ZC=0X MNI@LW@SV9?;U]NOLY^R7[:+;7F17["WV3KM09!^S4[M];6Y3QZIVN#?]4%$N M*;^OO\I;![TIDQ^\E]'[GTITY,IB)8;,D0# MH2(AK35YI+\D]-O[4^H#R]M;YZ)W<$3Z:&V=J]6?T?S@JM,.0C!]=/!ON'@B MZ$2:Y#W2?G>/)FU#4RARY,\"Y?0&0>23$^RYWS<[ZW0;B.9GOT@R<&32H'MV M5=[R!DM:@EVG\Z>G[VZ\;:)!\LA+M@=G[&JOD)QZ;U/KA\NJT/\BL7?Y5P07 MA&"/D@R\AM.+:>XL+MTABNGI#GVDC'-$ZG8K MM(7VTB'V_>0H)?1CP6JW+K=RULU%A?<6LD*FT*^&_;Z.$C^KJ,+A#I]J@ZB( M>*'%@/XV98QJC2V9L!2U8BQC@F4N]E6$+^3*2JNH6J[RCQB(21+U><\>FA=8 M\9U5H?UO]_M;TN:N;G<;!!TA>0ERXHX7'OK>F4/+9M_^_,XE]VU]@7]IP2(Y MA:,[;K2XMMS[1N_KDW^^CNBT]O"&>EY,E'Y0Q6MR?>WWO'MPX+D7]J=8*YB_ M.6(?"R\*=HQ.2^#W9V!)[/(I2U)XR6CL_5.VI'"82<7I3 I'\F_)_T'^Z?0S M^;_(_T7#F_D:$@F,DM=/EX0CN?DD'YL_+M'($4?Z4]0%#O*ZDE/>\&;#GQO^ MUL#K&K[30!LBR51QXT**V^' 4T("GHQRV(L/.&6SJU3)1"-N]1*=\H!"E'N]/" 9\+[BO>@5O*/DS.E%[7#(>D@\0]Z&I?+GERZIH:ZC8^K]N7J< MN8L\7GVE8UR^,M[A0^'[P!>:>C\(Y80X-'E6- 4K2(BE%+48PH**8CE%I>E2 M2\#"R:O64JJ3%)*L>/T5]PHL,[S%(Z",IJ+,G$BF-[,#&J;Z-D:VLHT_3N'/^ M*'E#R5F\T]U";1MQ?LN.'AZ5TE'\:.A)GPQJ6:2W$0IQ:#">P.C<^3Q)]1)UH MKE3(,Y^;7:I$J#+MV( M>5]CWUJ@6[M\ ML]T&IT1,VDQSH&KR(34N$06G?W)(HMUA&X?FH3$(]8:VR1^;[!:] MW2A+!LYB8J__L2437] P'X,%T*7H*=5>WY@2R2J,S$ U*J8LZFYN;AYH'FH^ MVBSX1LEY):.VW75(GC]_H5LNDJD9LU.1?(=\5!Z316#)JGGA5(*Q!/PR*JE# MU=VX?Z($LPFGBMFE)@CVG2[JB*UT&,Z M[,JBRPKU$BNIT'<,-#OUKMMW5F=R+N70 MG)SD0WJB[Z_B;L+0WY^L#5K*$O@2$Y]/KN23O)T>CTNK(7_'>W;>"\?A2>"V MLL]#)0[;=29B>MI M:!@]?/=5,3H0*OUV*MNG[=ON:;F\+AR<=*E^:Y_G!F MW;P@_YM:720L\_30P$!K33"X>LO.^7Z-9+1^JZNK]H:* M175UIV;\-_M> MS&=:;Y7M\'C@;0.$D"($@5\B"5(4)4B$ M>$LD+8D@15UV8LF.$SEV8LO.Q-8ZAS3:'+9KDK6=Q*(]J5K%:[O&UB:2/1,[ MEN.1IE9.,CO#1+6CV(YCD?M> Y2\-=ED9K=J:FK* %_WZ\9#H_N]__B^[SVV M]&SHO?]'5B.VZX_6?DF]1E>#"?!/BDD(,MN)D9$AK[=I:+@\,F2GJ&4(E;,.;K7BS!6\VXTT*;_KPID=#=*5;<(AKJD]OQ+ZQJ8EC#D*X_>#H MZ,"D]6#@('!)KJSKF.NTZRG71=<5%^=V15UC:!1<4PV/5NUH?W1SIFH'&) & ME '2/1 =.#WPU U-@ '!J8FUT$9CGXY!5!%8BMHD-9C'T"4'Y=__K?RCU(2 M2,ED$G]%16UPP52K\GL4MVI=T%N][EAJ?$3#B;PK!VK].;D.^Y;,6EDYQQ7- MZ#1BD!&(H!U&=SCCD7XR+QWDM(!X:1FEXXU6@\4LA/X16@>_(NA;)3U/.K4F M%&P0[:9$CM/PLE/N>6"QEN H"&TU(RZ3YH$#]0_?5B[H")TSN&@4*![QG<:) M$Z[*<;>-IR29FGO4:0BY#"2D2$@2C$ I190L!;:XGA!Y5N_?[K=;J$#QC2]Y M=W^VN\2IL]($XZ0@Q3($@UR6<4F\.7S7DW!_"HJLL?#>:H*A-9!._67N+ MOI-FP2;PN#(C^C_?2+2TMW_:YI1M-F=3??W=7J?L]3J]]>TV)\+U=>E0.DIT M=1G2'-$RW,2W-*6<\+03.IV \]J\?N]6[WM>NMY;\2T0L\2B,25&96,/(OKU MDX,V:&M/:;^L/:TEM]%D?NJ8DT":ZDWT,ZNJI")!+ U7L7*#1YP:R)/ M58]7V/*NMT#6J@DM[UXX*_ERZ,&DCI2:NVH1W4(C&4$$K-:+.;^)9S?: MK1Q!(^S8O/8KLIJL!,U@$''^^UXJA0];'K$2KVI?,K_4_>H@]6376?.SW>1C M78\-/FDE'],^9GTD2G9;NKL^5TF^T_5.]Z4^\F>62]9W6BYU4J^T_+CKQ]WG M^ZA7-*^:?FPFW]&\97K;3 *P4=/2WQ'Q-?J("[[+/L+GJ^B8T=M=]HB='+7/ MV_^KG3QJOV!?LY-Z.[3;ZS9. M 9S$*5R*HZYQ4.$.<^]R)/>11WHOL["H2D69=5T#)*\YM M.+7E1%*5\Z_'2=R=<=(%^T[NSGY__,"/'OY"5UFPN"KI37K3]8./9_N.G&W: MW'S@C=T+KTQ&"\/NX$9?4=?,U\ZU5[%]Y MEN& LJ$./]W/@B0W![;4G;'OO6B$QGLZ&K>^TK3S^-8"/55\S^#^ MT]^YJ_MVXHVB ^^,5#D(2A0TNF+8.K1Z=+7OEQV\# DCR[%,(3-&ZYMW+X\- M?RWF:>&M >V-AUI>>SJS^9GO_J=G [CO^]9^09:2<1 &]> U)=9FAF]JWM"] M84%0CP)@A(J.E,\ 2L&"F)N*H@I)47:_# R2P6V(&A0#;<"&.7%)"[73/ H3 M8MUV/_YIJISF8Q/A@%PG=\C#\BZ9EN4&)9P*CX6SX8MA&H;?"1-2V!V.HF,J M_,PN?HE_E_\GGN(G@%-R*LZ4D[KFA(KS7N=))^G\*+D^/AA&(_N45@PJ3&O, M6>FG512GAI>KQW6??O%%'#\RD,[I*F961N%@(VR$>0B=1VGQ=9B&A1QO#@RL MJW2D;75^4T64A[#WP=L2K1L[&5A^7X>GKZ-MUX'B4%$P6=XTG*E/]=]X/5)] M(\ ; YMKE]KCA$123E$0*AN>SI"D)5 ?8+G$L,P7A?_;_>'[^FH\45.!I_R! M>HM$,":]JS^TM1GYOG/M=^2'= SL!F>5P'/=YSWG>\@G/$_T/.B0FZ&>,9Y%U+*]=4>0^UT07F)D-S':KFCE2Y$V0R:L\A_E]; M<],=5)!4C6,P\HAX;3YLH"-D]5B"9_TJH?0UP)RJ6IB,B"KF16KJ M+D'8"R7SF.^ 4818Z^*UMCV$SJ$Y%*\D(*2(QJ+8P:8[^LH10**(1,(%?VI, M57(66N=+:@B*)BB+;K(I'BT>,6H@)C*0^*)H(>DB?=]?W"7(T&8667OS 1B< M[Q^_FA:M=IK5$@STN N_?/0;KQHM7;9@Y4Q#=E=B\@ZK(ZS5""Z&(A!Z-S(Z M073\JOM ;TVCU3#DE"O:N_@EI5W/>DA>I/&](HS'K'Q=&XRU5;M>HI,I%25EL;95\C4Z"HS"H1-M[X&RJK2V[9U;>LV>VJ:UMS%4[HGMJ=U#]6VQT\60 M2*1F-1.%$X&)Q@G*.0$GEF%8:3D^].C0MX?.#ET5PZC!S>*]GR\(9%$6/P;U9&BJJ^UZC*>RZ!$W?=2P_@M=1=)1N7$4I M##DN^L-J-@;9*%RBX;RZ@L<3(>NK-[T9X;"\EGID6M44/07S_0W$/KW1O=O8.5I:6(/ME<>V(&'\[OZ' ]]V3M2ZMAA$U M1B%FI;>&^@^]_-XF' M5N1?4.]11!$)M20$,_ L PUI*[8[NSOMP*:EM0NG(J#S12JP*:RO:+F>D*YF;ER]?CTIY=Y7,YEUTIT+^HL@8ZJ)YR*\ MQ*Z/FQH/(BA^JRB<4(TF!Y!BA9ZJB0BD25YSA\CQ&G;B,X]+'*/]C(FDT&B2 MEM(X]::%%Z3B*/O1^:]GF*S6J&,I0>1)BH4LS0N\1>\H_?8O?OWK R4NO07U M7B8Q4UL[$1BK!3&9D>$9);]^AG7'K4"@V]AM1 M*$;8D>V!D!3YQ8(_2V.>.#IKXS8.\%%,;_ M1=EU/)==%U!Z7;F57Q&XS$58QXHM(B4=*]=7(KR/ ?"BW'@P+O-CG MU$' @J!U'5\Z81',+6>ERS]XL 3YCWE,8DSWW-W9P+ %E4462=4% M8[&M+<>2V"MH+MHHR"R<_5F/;"?<:.1LH5(4)*HW&@O%4ME=W@LC]\QR\Q MG& D:+U,$EH69]2NM7?)\V0,\2,7F%#<'&$CB%KOWOE4_L&#\+G M-WUQJ.GXCN;/CWX3/MSZE3N_GYT?5IXOSTSJV%%SET@ )%"5M&\?6;!8KA M"C=X9&JVM J9)21\":M.V^X)U\D%)=).?:%8&'#1R+PH:8^L8T,&GIL/-NRJ M1>%7I]'3O%:!0[.%',TY0Z[R+ECU%P9&V[;!*O'!^I#'9/?PEM;JT#=?]@BL MP",\!D5:8 0\08K[?F'M"O$E,@GJ(%2>^1O?1?_K@;?"U O^%P,OA=[44B]H M7M2^Z"/_6OQK#7&_]B4= C0@$7P17\GP!R ME-Y>(5K=VV7V60U$+1!<+9&*#C[H@%MQRR /#EKCOG@\WAZGXO&$]"$/!1[R MAXX%UX)$*C@6/!8DI6 V2 2?+CD$I!Q['T"<_GV)C4J*1*2D$Q+!(V+?(CT' MQQ&R>R^_%!'SHY6%'(?/9?>%E=QB-)3]5Q+H+R=J&W**]DT].[.@ZBVU.%=C M(I37JW-TWX*!.(H-ZV*WD\Q+W3Z_NC(M_I#7Y)O;F*@+1"*KORLO[[Z[MF.A M#.4\+:]SWI%,=CN=[TQ'=WP^?O0V <45876T,-%8Z:ULJHU/UM5UML[46*S5 MDVZX>;RKOKRD9'OOOJJVPY41SL++Q^UX92:H6_L'(D/^'"'G*45351DEJT<0 MDC(\B4R]2+&PS(-NZ'873/G%TM(L7M[11&X!6! P6LZ$XW%%"<-L^%B8"(=S M2#>S8,0H:04;>Z8Z AIO5$4R>*581+JNSBF[()N?O50MM41/H$A)RGG%&%LV MF]=#:A$DBD ]S*E1.648.ET48:(=79&0'" 8PU=ZC1Q)%#ABCDZ+E^=%&)H? M:=IBHR!A&.1$4>]SM-DT%HG\.1R] PN\LD9;2!.$O?B1U0]F/"4272CR;"24 M'+SO[_8$"@M1OA18C5X2&[QR71GJG>*U%?(R:0 CX'6EO%PJ5[JE;F6[M%UA M7HK_-/YN_+=Q2K\3ZG=&=O;O) T;6R6;/=$J:?0)W?+:!XK-8DWH"M/%Q2-I MDCE7=;'J2M6U*JIJ!N4[H!0F1-UTJ[AQB][I0ICBB!7S2O\5/W'9#_TX 58+ M9RZ@6]A[JO-TY[E.TMV9[3S6>4(]8**=2F>JZY$XDB'_=066A0(%O$WGM5X>6T#_-SF8BL-M8;^;?6UL\TMD,)$E(!2HU]/ M&A!$-7WQGC[QJ6TU#6%?Q9=C+NN9H$BI^) @8-?)*P/W2B3-:!FQJ$BD2[@! MVH(N&BSJZ_NAX(B:6*^DX1NU!FU-H:0UT R :]?7WB!?)QV@%_Q:$8P-A9U$ MH=7H));7/J^4.5I;W)VMK5F'678XS TM+6,.)ZHYS9V.!B?=VA-/^])11IMF M,7XD>M24H'@)IN5B*VP53_7#UA:'H]?9H _T!W8'#@4>#+P?8"*!HP$B@%F* M!<2RL6LQ$L2D6"HV%CL=HT_$8&P9/JTXS)U /":>%DE)A$!TBUGQF^)/Q7=% M1ER&]_] Z3W62_3BR;7%A40B'XT2"2SM)Q(98&M<2*[GE3^@[N,5!9D,:;%6 MJ6P2O?,T8GUQ<)-P,"Q9@I@(J2[?%.8Z*Q5 MQ]",P=A3S:)AG6I)^)L5HT06N-DAEH$V\:"F_)0;M7!IV&%9[]87Q43M5YR\ M=M/WXI8##.F #-89(,$+(@TY/4T+9MIT[9L+W5]_,MJA$S1%/-11+$I!",R2 MA,"+'(2<)(Z4M]U9X%Y]S.;X<_B?;Y?=$HNMU.7%IA:A\V6&!C,(OZ=JAT<'HX[LO/S M!;;%5"J;L,F)A*T@/CP\-E\@H[.IQ/SPHBU>P(%D5[H3#WUS,JW@Q0?-PFWI M&7QB,I,>1_NSDT)5.N!.E^(/ PQ(T_A#SIC68$-YC&-FXW@QYTF4G@I\"Q!5\R6CR6/)$ M\G3R7/)*DD\E)Y)+R<^B$Y>3OTBR/TW"9/+(H@WH)?T)/:E_F2 .#\^#4=-H M:G37Z,'1SXT^,OJMT?='>684CK[TP1Q,S8W-9>>.S5'2W(DY8BZR;E'(H&[D M=GA=**HM9#ZESN2B3ZV)C[$5:>56];V;-H?H[?$0=MK1UA 4;2^F[3)SM0'"GM[0=12;! M'@I9]A16: D)!3Z?]X&'ILIC59 R?D,8+K!;/:3>6&W1WEL?K"XR>FP;_!)) M]':-;!8T#HK0F5MFOO?9!QA>*B@C5K2\EB()J$,8G6!%FI-<)\-W=LA6EZ#A M$#HB$;&E.8KB7-:J<\\>CSJU&A0*:13SG"0E&$2MY4Q'L+?<$BC@35J.UK*, MEJ()':ME"7;X^NDG&8:GN9O_)=/]L3+TKRP?(9CV "I_FRO$ZP"0+]PJ]!0 MK!$ [C$ ^/^>*\*' (AW__&BW02 ;@X!_[I<,9;^G\4T]:>+C.[-*N6*[5O_ M\N(XF2L%#P-0I / ^6>WBOMV (H_S)52]-S>5W/%CYXK\,BM$D3/''H6@/#? M %#Q) #1>W*E>O&3\DGYI'Q2/BF?E$_*)^4_=@%X)@6_9$#B&G2@PH _^2(_ M5M=+!F"2$8ZSV1V@L"A_UNOS@S*T+U]O%J\%B5M?:@7M'9T ]&P"??U@8!" M+<-;MZ7!#O#OY$6!TVA;"MRH1J%M!:@$M6 #OF^$PX? ,!@'TV 6[ 'SX" X MO+:&6KM!&$1!##UFL]IJL]IJ$LR V\ ^L(A;K?V//_7.C\>_;@C^\$L#'KEY MM1\!D*^30(^.8/XI]>!BOLZ@^N5\G45/]6ML$11>U'TWS.3K$#B)R_DZ 73$ MC7R=!$Y2S-R1Q=G= M,TONWOE]\TM'LM/NH2/9^=V+X]F9(V'WIJ4I=V4B45F.-C45[J8]>]QJZ_WN MQ>G]TXL'IZ/NI<7QJ>F]XXNWN>=W_=^O?FAF M=G+&O7?\B'MB&EUT]^S^I>E%='>S^]R3TXM+XV@_=V!Q=O_4[.32[/R^_16; M6KO:._M"ZS_VQP__C>\-&>3:/]--H?5.^FX@_^8@?Z'?Q;>]5/IL!WT;E9 M]?OXKI?4SZ90R[UJN]O0N7FPZ__IW@^A,[.J0[K5JQU!^PGUF_A.=ZN_NJ3> M;Z[O9M'U<;_A,[@/<\=SX(#ZG/M1&WPUW-OX3O:CY]N$QJ +.7\GZ .A?_9D M@^JO'$ ]A<__\;;_/Y_^Q^[C7"0C'@7_"R3!ZP"O^95 !,5F0&T@WE?S&(YB MQ*Y=@Q_V%([JD[\%!3DQY3NZ4VI\^^'#[W^P>O7&%[B[V*OHD,]_ _QO 08 M]ZK76 T*96YD'AXC("@H)24H*#(R,#(R.SL[.SL[.SL[.__ !$( M &T!YP,!(@ "$0$#$0'_Q $_ !!0$! 0$! 0 # $"! 4&!P@) M"@L! $% 0$! 0$! $ @,$!08'" D*"Q 00! P($ @4'!@@% M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7% MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34! M (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$ A$#$0 _ /54DDDE+)I3@H-V M7C4?S]K*OZ[@W\I24 3LFU3JK3GX5SMM-]=CO!CVN/X%69T2201N*722220I M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I) M9^9USI.!8*):]ID$)*2))))*4DDDDI M22222E))))*4DDDDI;A,2 GY7/?7CJ;^G]!M])VV[*(I81R-WTC_ )H*5TOQ MP.2<8#>1IYOZT?7K(?<_!Z0_TJ6$MLRF_2>1R*_ >:XQUEU]FY[G6VO/+B7N M)^KE/$O+E(QA"/%.6P'S2\27SNKZO=?L:'U8%Y!X.PM/XPM#%ZO];^@. M'J"]M#>:\ACG5Q_6/'R*T^H_XR\^RQS>FT,QZAP^[WO/GM! 'XK/'^,'ZQ ^ M^RBUAY8ZH0?N(2T&Q*OZ3D'ZS#C,?W92U_:]E]7OKKT_K!;CV?JN8>*7&0__ M (MW?X*7.YWDVV1YZQ^*EB#6KEEK^IW>G_7+H^8X5O<[%L/ N@-)_KB1]ZWP01(,@ MZ@KQVZFVBQU-[#78PPYCA!!^"WOJS]9K>G6LQ,IY?A/, G4U$]Q_)\0D8]E" M7=]%23 @@$&0=04Z:N4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI22 M222E))))*4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI222BYP:"YQA MHU)/ 24J4N>%P(_Q@=5R^J?8NG8U+Z[;?2H<_=);,;G0?#5=XT$@ \QK'$H M @[,N7!DQ4+L?J'7DLZ38;014 M^TF@'P@;B/*5OWX6'DD.R**[BWZ)>T.(^\(S0UK0&@ #0 < )Q.C"!1MDDDD M@E22222E))))*4DDDDI22222EEPW^- G[-T]GYILL)^(:/[UV\^Y)^#P6_EA"6Q;')$#F<=]Z^T.7_BRP66967GN$FAK:J_(OESOP 6 M?]?>L69_6'8C7?JV#[ WL;/SW?P6]_BN(_9^LQS MSE9A83_7L@IA^4#NZ.,"7.9IR_R417AH[?U2^I?[4J&=GES,(_S53='6><]F MKJL[I73L.JOI_2L&AN9E2&.G=?Z1UQCL8@;W#W M8UP&H\NSERWUK^K3>FN&9A@_8[##F<^FX\:_NE+P(5J-07H^L])POK#T]N7B M%KKPW=CW#\X?N._UT7G3FN:XM<-KFDAP/8CE=/\ 47JCZJ^I?479G21589LQ'>D2>=L M2S\-%T!7#_XO+",O,J[.K8[YAQ'\5W!,! [KALAR\S&PL=^1E6-IIK$O>XP MN"ZQ_C(R7O=7TBL55#3[1:)ZI]EQMS\2I_IX]3?\(^=N M_P Y/"ZSZL_4G#Z?6S*ZBQN1G$3M=[F5^3>Q/FH[)-!T88,/+XQDSCCG+Y"P/8SY;=K4G'ZZ8/Z1QSZ@W4N.]S?G](+UP #0:#P3 MP?%+@\2M^_C88,?#V?,NE_XQ>K8S@S.:W-J&CG !EH^?T3]R[_I/5\#J^(,G M"LWLX>TZ.8?W7M[%9WU@^I_3>KUNL:QN/FQ[+V")/@\#Z07-?5#H/UCZ?UMU MA8,?&J<:\HO/MM:/]&!SX@I#B!HZA60P'.=,ZCG_ %9ZRYSVECZG>GET'A[)_P!2TKU[&R*L MC'KR*7;JK6A['#N'"0C$VP+'/6)_8\]]>NKY_2NGX]N!;Z+[+MC MG;0Z6[28]P*S.B_72RCH.1U#JMOVB\7FK&8 UKGG8UVWV@<3J4?_ !G3^R<4 M\_K'_?'+B_JWT=_6NJ589);0V;+R.S!$QYNT"!)XM&UR^'#/E.+( .&1E*5> MJATMN9'7?K7UVU[Z'7FMI_FL5K@QOD2SGYE=/]0*^ON&1D=2NN^S-/IU4WR7 M%P^D[W^X <+K,7#Q\.AF/BUMIIK$,8T0 C(B.MVU\W-QG XX8HPCT/5P/KKU M+.Z9T<96#;Z5OJL9N@.T.Z=' K#^K?UQO'3<_/ZU?ZWV=[&T-#6M*<4.AH_E.;J3\5O?4.OZQ.S+ MK,^Z]N)2-AIODEUA\/4U&T>"Z_I_3\3IV,S$PV"JJL0 .2?$GQ*M:<=_!$1U MLEKY>;A*$L>/%&$3L>JY*X_ZQ_7W'P+78?30,G)9(?83^C8?#^443Z^?6)_3 M<-N#B.VY>8#+QRRKASAYG@+F?J=]5&=8<]>.TM:/E6/RIG-^N6,/5=^T*P/SOT MI'\5ZUC8N/BU-IQJVTU,$-8P!H'W(WS0X/%<>?B-(X("/9\MZ5_C ZSB/#,R M,ZD&'!P#+!_: _*%Z%TCK&!UC$&3AOW-X>PZ.8[]UP[*EU_ZJ=-ZQ4Y^T4YD M>S)8(,_ROW@O.^G9W4?JMUUPM!!J=Z>74/HOK\1\M6E*S'?4+CCPV05PG0/KQU>SK%.)U9[/0M<:7@,#"R MPZ-D_P!;1=_1=7?2RZIV^NQH>QP[M<)!7F?U^Z2<#K'VVH;:<[WR.UK?I_?] M)&5C4,7)1QSE/#DB+F#PR(U!#ZB"DL?ZJ=7_ &OT:G(>9N8/2O'\MNA/SY6N MG-6<#"1C+>)HJ"Y?Z^]9^P='.+4Z,C.FML;&%XQ\1H[@&-W]HZILC0\VQR6'W,O%+Y,?JE^QV_\6W1O4OMZM:WV4S5C MS^\1[W#X#1>AF/N5+H_3:>F=.Q\&K5M# "[]YW+G?,J\1*,108^9S>]EE/IM M'R&SP'UQ^L_6^F=;=BX60*J14Q^WTV.U=,ZN!77=!R;LOHV'E9#M]UU+'V.@ M"7$:Z!>>?XQ/_%*[_B*_^_+OOJO_ .)WIWA]GK_(@#ZBV>9A ?!H5C.S:,##NR[W;::&%[S\/#XKR3*R> MI_6?K0V@ONO.VBK\VNL?D &I*4I5YL/*\M[Q,IGAQP^8_L=3J7^,3K.4\MPM MN%3^; #["/-QT^X+.'5?K;=^E&1FO'()@_P AI^B/Q70 0$.$G[=C9 T<'#7:Z.'!+6/B%T?NW-7'@&'+TK8_ MQ?7M.$_>%SWU.^L'[9Z1]LQH9>/WOW7_VORKH"=(3P;:&3'+',PEH8FF2 M2222Q:=5G]%?/)2Y23&1B1(;@V/H^(:W.#FS^[:=S3_P!):?UIP;OJ]]8L M?ZP8;/U>VP.M:. \Z6-/]=O'FH_7K&F_ ^LN =U-P9+Q^\WWUN/Q&GR4?3^Z M76C(3R\8^7FL9AY3'1]$E5,]E]H%.*[T[7B'7Q)K9W+?Y1[*>#EU9V%1EU&6 M7,;8WX.$JSP%(Y!!!(/1H8/1.G8(_0TM=8=7W6>^QQ\7/=JC9?3<#,K-630R MUI\0)'P/(5I))3YIU_I%W0>HUV8KW"IQ]3'M_.:6G5I/DNS;8SKGU<+W@?K- M!W#P>!_!P6?]?JVNZ538?I,O:&GRI#Q/0'O9UO!+>?68#\S!6O]?B#U>D#D8XG_ #WJE]4L5V5UW',>VDFY_EM& MGXE1^M.:W,ZYD/899414T_U-#^,H]4='8_Q?4$VYN1&@:RL'S)+BMSZWYSL' MZO9EK#%CF>DP^!L.S^*A]3^GNP^C,=8(MR3ZKAW@_1'W*M_C#!/U;L(X%M9/ MPW)DSNS\M$'+C!V,H_F\O_BXZ=7D]6LR[!+<)@+ ?WWZ _( KT[E MHUS[SZ3@/(;PN^!DQX)L-F?XA(GF) _HB('V6R2223FHI))))3'M"\?^LF1; MU/ZS90:9+KAC5>0:?3'XKV$KQN15]:P;= SJ$OG_ (U,GT;_ ,-TEEEUC#1] M:Z?A58&'3ATB&4L#&_(T2222=25TDDDD/GO^,OIS668O5&-AUDT7 M'Q@;F'\H6M_BZRW9/0?1>9=B6NK']4P]OY4+_&:Y@Z+0P_2=DMV_)CY0O\6( M<.FYKS]%UX ^3!*9^FZ$CQ?#P9?H2]/VL_\ &?\ \DXG_AC_ +XY5/\ %?CM MC/RB/=-=0/D 7%6_\9__ "3B_P#AC_OCDW^+ ?Y*RW>.1'W,:E^FD&OAQ\95 M^+VB222>YSRG^,?_ ,3P_P"/9_WY8?\ BQH:[J&9D$2:JFL!\-[I/_4K<_QC M_P#B>'_AAG_?EG?XKF#T^HO[[JF_@XIA^<.CC-?#\G]ZOQ#WB222>YSX[]<< MU^9]8\UQ,MJ=Z+/(5B/RRNMZ5]=OJQTWIU&%4;0VA@:2*SJ?SG<]RN,ZO2#] M8LNNTEK79;FO=W <_4_<5V0_Q8],X&;D>>C/_(J,79(=CF!RXQ889C*(X;CP M^3=_\<7ZN^-W_;?^U+_QQ?J]XW_]M_[53_\ &NZ9_P!S'D/W\G\OHV_\ QQ/J]XW?]M_[5R'URZOTKK&;1F=.W^H& M&N_>W;(!EA\^2NC_ /&QZ9$_;9=C/?5\@=S?PSM_:&B)]7OJ_1T+$LQJ+7VMML]0FR)!@-TV@>"U^R3*!GEDQ[<7% M%\P_Q?=7^Q=7=@VF*<[0 ]K6_1^\:+TX&0O)/K3TZWHGU@>_&]C'N&3BN';6 M2/[+EZ=T7J575.F8^=7QGJ-&ZYP[O=JY#>7DOG_1^4 M$=LF?4^7^\ZR222>YSY7_C$_\4KO^(K_ ._+OOJM_P")WIO_ (79^1<#_C$_ M\4KO^(K_ ._+OOJM_P")WIO_ (79^1,C\Q='F_\ ;;GFFL^#&071\7?D5;_&DUXLZ>[\W M;:/G[%N?XO\ 9_S9H Y#[0[X[RE^FB1X?A\>'].7J^T_P>E2223W/8SV69]8 M^ELZIT?(Q2)<6E]1\'M]S2/FM2-5%Y#6.W< $GX)+H2,9"0WB;#Y5]0LUV+] M8J:R89EM=2X><;F_B%ZH!(7D'U7]WUGP=G_<@D?#W'\B]@'9,Q[-WXF![T3^ M] 7]K-)))/:"DDDDE-3J.!C=0Q+<3)9OJN;#AW\B/,+CL.@],==]4NN$OZ?F M3^SLL\23(;/9P.H\_BNZC4GL54ZETW#ZEB.Q,NL65/[<$'LYI[$($,V+-P Q ME? 3>F\9#:4?%YKZH9>1TO,M^K'43%U)-F&X\/K.IV_E^]=?$$KDNH]#RG55 MX^=:]YQC/3^KL$VU$<-O:.1_*'SA:W2.JVVN&'U%@HZBULPTS7SM))B8$K-S,CJMX./TZGT2[0Y=^C6CQ8S5SC\ M82:[@?6RVSJO4L7H>)[GM=ON(U#21^=_5;JB_6S,HZ9T>KH^,??8QK".XJ;R M3_6*E5=T[H8LIP [JG6+_P"=0SXE'Q>F=7^M.<K?L3K;;;Y94^:,D'\T$\G^JX+UQKF/:'-([7*QV\N/^D;XGQ"QOJY]=LSI#&XF2PY6$W1K9BROR!/ M(\BF \.A=+/B'-P&;#7&!4X=7U1,?-8&+]>?JUD,#CEBAQY9V?T([DE]%.J\I^O73+,#K]E[1%6;%U M;OY8T>/D=5ZOV61]8^@T=[&L(9:P[\>W]Q_\ <>"C(6*6F M7EW6^K?6J^L=*JR6D>LT!F0SNVP#7[^0MQ\QX$+M^G_ .,3HF0P#,+L*W\X/!UT?FL:\G_J5R_7_P#&%=EL?C=):['K=H[)?H\C M^0!]'XHF0&['CY3/DE0@8^,A0:OU^ZU7G]4;B4.W48(+7.&H-KOI1_5B%VGU M,Z8_IO0**K1MNNFZT=P7Z@?)L+D/J7]5+'_'L_P"_+._Q7?S'4?Z]?Y'+1_QC_P#B>'_'L_[\L[_% M=_,=1_KU_D5/ZQ]#HZWTU^)8=E@]]%G[CQ MP?@>"O,\3,ZQ]5>JO:6&NUNEU+_H6-\?,>!"9\IOH71@!S7+QQV!FP[7U#[% MRFA7S T<D6UA MY2..$LO,BHUZ87J2^EX>4S,Q:LEC7,;

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image_001.jpg GRAPHIC begin 644 image_001.jpg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end